Management of malignant pleural effusion

被引:10
作者
Tattersall, M [1 ]
机构
[1] Univ Sydney, Dept Canc Med, Sydney, NSW 2006, Australia
来源
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE | 1998年 / 28卷 / 03期
关键词
pleural effusion (malignant); pleurodesis; chemotherapy management;
D O I
10.1111/j.1445-5994.1998.tb01972.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Malignant pleural effusion is a frequent cause of morbidity in cancer patients. Pleural aspiration relieves dyspnoea usually only for a matter of days, and if the tumour type is not chemosensitive, some form of pleurodesis is commonly required. Tube thoracostomy is widely used to achieve pleural drainage prior to attempting pleurodesis by instillation of a variety of 'sclerosants'. Recently thoracoscopic instillation of talc has been advocated and some authors report high rates of fluid control. Randomised trials comparing this approach compared to tube thoracostomy and chemical pleurodesis are required.
引用
收藏
页码:394 / 396
页数:3
相关论文
共 17 条
[1]  
ANDERSON CB, 1974, CANCER-AM CANCER SOC, V33, P916, DOI 10.1002/1097-0142(197404)33:4<916::AID-CNCR2820330405>3.0.CO
[2]  
2-U
[3]   How should cancer presenting as a malignant pleural effusion be managed? [J].
Bonnefoi, H ;
Smith, IE .
BRITISH JOURNAL OF CANCER, 1996, 74 (05) :832-835
[4]   CARCINOMATOUS INVOLVEMENT OF PLEURA - ANALYSIS OF 96 PATIENTS [J].
CHERNOW, B ;
SAHN, SA .
AMERICAN JOURNAL OF MEDICINE, 1977, 63 (05) :695-702
[5]  
FRACCHIA AA, 1970, CANCER, V26, P626, DOI 10.1002/1097-0142(197009)26:3<626::AID-CNCR2820260320>3.0.CO
[6]  
2-3
[7]  
HARTMAN DL, 1993, J THORAC CARDIOV SUR, V105, P743
[8]  
HAUSHEER FH, 1985, SEMIN ONCOL, V12, P54
[9]  
MARTINI N, 1975, CANCER, V35, P734, DOI 10.1002/1097-0142(197503)35:3<734::AID-CNCR2820350328>3.0.CO
[10]  
2-N